Literature DB >> 4552917

Combined chemoimmunostimulation therapy against murine leukemia.

J W Pearson, G R Pearson, W T Gibson, J C Chermann, M A Chirigos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4552917

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG).

Authors:  E Robinson; A Bartal; Y Cohen; N Haim; J Mohilever; T Mekori
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Comparison of strains of BCG. I. Antigenic analysis and tuberculin reactivity.

Authors:  S D Chaparas; S R Hedrick
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

3.  Personal experience with Corynebacterium parvum in human cancers.

Authors:  L Israël; R Edelstein
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

4.  Virulence of six strains of Mycobacterium bovis (BCG) in mice.

Authors:  N A Sher; S D Chaparas; J Pearson; M Chirigos
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441

5.  A patient with gastric carcinoma improved remarkably on intraperitoneal OK-432 therapy.

Authors:  H Yamagishi; H Ishibashi; M Kodama; T Tanaka; Y Harada; I Hashimoto
Journal:  Jpn J Surg       Date:  1982

6.  Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy.

Authors:  L Tentori; M P Fuggetta; S D'Atri; A Aquino; C Nunziata; M Roselli; P Ballatore; E Bonmassar; L De Vecchis
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy.

Authors:  S D'Atri; M P Fuggetta; G Giganti; L Tentori; M Roselli; C Nunziata; S Pastore; E Bonmassar; L De Vecchis
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages.

Authors:  C F Nathan; W D Terry
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

9.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

10.  Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.

Authors:  G A Currie; T J McElwain
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.